Tardive Dyskinesia is a condition that affects the nervous system, commonly caused by long-term use of anti-psychotic medications. The most common symptom is sudden, uncontrollable movement of the mouth, tongue, jaw, and or limbs. Many individuals with TD are not aware that they have this condition. The Michigan Clinical Research Institute is a site for a research trial which aims to reduce symptoms associated with TD.
What to Expect?
First, a consultation visit to assess eligibility and ensure your interest in participation.
Participation will include taking a medication on a daily basis and regular site study visits.
Study visits consist of psychiatric and physical evaluations, along with vital assessments such as EKG, blood pressure, and laboratory tests.
Medication and care related to research will not be charged.
Families will be compensated for their time and travel.
To learn more about participation, please call (734) - 800 - 5848, or fill in the fields below.
*Disclosure: Dr. Rajarethinam, the Principal Investigator, conducts contract research for various pharmaceutical companies, including: Johnson & Johnson, Neurocrine, Otsuka, Astellas, Jansson, and a variety of others. He also participates in promotional meetings for Neurocrine Sciences.